Literature DB >> 2574789

Human recombinant soluble CD4 therapy.

R J Gerety, D G Hanson, D W Thomas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2574789     DOI： 10.1016/s0140-6736(89)92960-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  1 in total

1.  High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.

Authors:  E S Daar; X L Li; T Moudgil; D D Ho
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.